Differential gene expression in the proximal neck of human abdominal aortic aneurysm.

[1]  J. Golledge.  Targeting chemokines in aortic aneurysm: could this be key to a novel therapy for a common problem? , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[2]  J. Hamming,et al.  Activator protein-1 (AP-1) signalling in human atherosclerosis: results of a systematic evaluation and intervention study , 2011, Clinical science.

[3]  A. Bolstad,et al.  Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome , 2011, Arthritis research & therapy.

[4]  J. H. van Bockel,et al.  Immunosuppression and the abdominal aortic aneurysm: Doctor Jekyll or Mister Hyde? , 2011, Circulation.

[5]  P. Tsao,et al.  Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm. , 2011, Physiological genomics.

[6]  Y. Li,et al.  Mycophenolic Acid Differentially Impacts B Cell Function Depending on the Stage of Differentiation , 2011, The Journal of Immunology.

[7]  J. Golledge,et al.  A single nucleotide polymorphism in exon 3 of the kallikrein 1 gene is associated with large but not small abdominal aortic aneurysm. , 2011, Atherosclerosis.

[8]  J. Golledge,et al.  Current status of medical management for abdominal aortic aneurysm. , 2011, Atherosclerosis.

[9]  J. Golledge,et al.  Animal models of abdominal aortic aneurysm and their role in furthering management of human disease. , 2011, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[10]  Jonathan Golledge,et al.  Thrombus volume is associated with cardiovascular events and aneurysm growth in patients who have abdominal aortic aneurysms. , 2010, Journal of vascular surgery.

[11]  J. Golledge,et al.  The novel association of the chemokine CCL22 with abdominal aortic aneurysm. , 2010, The American journal of pathology.

[12]  Adam Parr,et al.  Relation of infra-renal abdominal aortic calcific deposits and cardiovascular events in patients with peripheral artery disease. , 2010, The American journal of cardiology.

[13]  J. Golledge,et al.  Pathophysiology of abdominal aortic aneurysm relevant to improvements in patients' management , 2009, Current opinion in cardiology.

[14]  J. Golledge,et al.  A Systematic Review of Studies Examining Inflammation Associated Cytokines in Human Abdominal Aortic Aneurysm Samples , 2009, Disease markers.

[15]  S. Swain,et al.  Age-associated declines in immune system development and function: causes, consequences, and reversal. , 2009, Current opinion in immunology.

[16]  J. Golledge,et al.  Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm , 2009, BMC Genomics.

[17]  E. Choke,et al.  Whole genome-expression profiling reveals a role for immune and inflammatory response in abdominal aortic aneurysm rupture. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[18]  A. Bolstad,et al.  Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice , 2009, Arthritis research & therapy.

[19]  G. Getz,et al.  Lymphotoxin β receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE−/− mice , 2009, The Journal of experimental medicine.

[20]  L. Joosten,et al.  The molecular signature of oxidative metabolism and the mode of macrophage activation determine the shift from acute to chronic disease in experimental arthritis: critical role of interleukin-12p40. , 2008, Arthritis and rheumatism.

[21]  I. Baumgartner,et al.  Severe structural damage of the seemingly non-diseased infrarenal aortic aneurysm neck. , 2008, Journal of vascular surgery.

[22]  J. Browning.  Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease , 2008, Immunological reviews.

[23]  I. Baumgartner,et al.  Aortic neck dilatation after endovascular abdominal aortic aneurysm repair: a word of caution. , 2008, Journal of vascular surgery.

[24]  H. Kuivaniemi,et al.  Aortic Aneurysms: An Immune Disease With a Strong Genetic Component , 2008, Circulation.

[25]  K. Jamrozik,et al.  Obesity, Adipokines, and Abdominal Aortic Aneurysm: Health in Men Study , 2007, Circulation.

[26]  Gerard Tromp,et al.  Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms , 2007, BMC Genomics.

[27]  Guowu Yu,et al.  Tertiary Lymphoid Structures in the Pancreas Promote Selection of B Lymphocytes in Autoimmune Diabetes1 , 2007, The Journal of Immunology.

[28]  R. Berguer,et al.  Global Expression Profiles in Human Normal and Aneurysmal Abdominal Aorta Based on Two Distinct Whole Genome Microarray Platforms , 2006, Annals of the New York Academy of Sciences.

[29]  K. Cherry,et al.  Aortic Neck Dilation after Endovascular Abdominal Aortic Aneurysm Repair: Should Oversizing Be Blamed? , 2006, Annals of vascular surgery.

[30]  Bing Zhang,et al.  WebGestalt: an integrated system for exploring gene sets in various biological contexts , 2005, Nucleic Acids Res..

[31]  S. Money,et al.  Late problems at the proximal aortic neck: migration and dilation. , 2004, Seminars in vascular surgery.

[32]  H. Schumacher,et al.  Morphometry and Classification in Abdominal Aortic Aneurysms: Patient Selection for Endovascular and Open Surgery: , 1997 .

[33]  A. Campos-Neto,et al.  Chronic inflammation caused by lymphotoxin is lymphoid neogenesis , 1996, The Journal of experimental medicine.

[34]  J L Browning,et al.  Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. , 1992, Journal of immunology.

[35]  J. Hoofnagle,et al.  Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis , 1986, Hepatology.

[36]  R. Palacios,et al.  Cyclosporin A – Usefulness, Risks and Mechanism of Action , 1982, Immunological reviews.

[37]  K. P. Murphy,et al.  Janeway's immunobiology , 2007 .

[38]  J. Capella,et al.  Features of autoimmunity in the abdominal aortic aneurysm. , 1996, Archives of surgery.

[39]  J. Golledge,et al.  Atvb in Focus Abdominal Aortic Aneurysms: Pathophysiological Mechanisms and Clinical Implications Abdominal Aortic Aneurysm Pathogenesis and Implications for Management , 2022 .